Shattuck Labs (STTK) Equity Average (2019 - 2026)
Shattuck Labs (STTK) reported Equity Average of $89.1 million for Q1 2026, up 21.07% year-over-year from $73.6 million in Q1 2025, and up 1.48% on a QoQ basis from $87.8 million in Q4 2025.
Shattuck Labs (STTK) has 8 years of Equity Average data on file, last reported at $89.1 million in Q1 2026.
- Quarterly Equity Average rose 21.07% year-over-year to $89.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.1 million (up 21.07% YoY) and the FY2025 annual result came in at $81.0 million, down 27.78% from the prior year.
- Equity Average improved to $89.1 million in Q1 2026 per STTK's latest filing, from $87.8 million in the prior quarter.
- Across five years, Equity Average topped out at $260.4 million in Q1 2022 and bottomed at $62.3 million in Q2 2025.
- The 5-year median for Equity Average is $125.6 million (2023), against an average of $135.3 million.
- The widest annual swing landed in 2025, when Equity Average tumbled 47.96%; it then increased 21.07% in 2026.
- Tracing STTK's Equity Average over 5 years: stood at $187.8 million in 2022, then slumped by 31.44% to $128.7 million in 2023, then sank by 31.57% to $88.1 million in 2024, then fell by 0.33% to $87.8 million in 2025, then gained by 1.48% to $89.1 million in 2026.
- Per Business Quant, the three latest STTK Equity Average figures stand at $89.1 million (Q1 2026), $87.8 million (Q4 2025), and $75.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Shattuck Labs | 667.80 Mn | 667.80 Mn | - | 89.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.11 Mn |
| Dec 31, 2025 | 87.82 Mn |
| Sep 30, 2025 | 75.13 Mn |
| Jun 30, 2025 | 62.30 Mn |
| Mar 31, 2025 | 73.61 Mn |
| Dec 31, 2024 | 88.10 Mn |
| Sep 30, 2024 | 103.60 Mn |
| Jun 30, 2024 | 119.71 Mn |
| Mar 31, 2024 | 136.76 Mn |
| Dec 31, 2023 | 128.74 Mn |
| Sep 30, 2023 | 125.62 Mn |
| Jun 30, 2023 | 148.06 Mn |
| Mar 31, 2023 | 166.91 Mn |
| Dec 31, 2022 | 187.79 Mn |
| Sep 30, 2022 | 210.97 Mn |
| Jun 30, 2022 | 235.73 Mn |
| Mar 31, 2022 | 260.36 Mn |
| Dec 31, 2021 | 266.48 Mn |
| Sep 30, 2021 | 269.13 Mn |
| Jun 30, 2021 | 287.87 Mn |
| Mar 31, 2021 | 304.26 Mn |
| Dec 31, 2020 | 125.75 Mn |
| Sep 30, 2020 | -52.69 Mn |
| Jun 30, 2020 | -43.95 Mn |
| Mar 31, 2020 | -37.70 Mn |
| Dec 31, 2019 | -30.91 Mn |